Re: New Interim Financials and MD&A docs on SEDAR
|
3
|
Resverlogix Corp.
|
Dec 16, 2015 12:42PM
|
Re: New insights from this study -- Questions for scientists.
|
10
|
Resverlogix Corp.
|
Jun 08, 2022 12:06PM
|
Re: New insights from this study -- Questions for scientists.
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 12:18PM
|
Re: New Frontiers for both RVX/Zenith
|
2
|
Resverlogix Corp.
|
Apr 18, 2017 10:16AM
|
Re: New Fact Sheet
|
1
|
Resverlogix Corp.
|
Feb 05, 2019 01:28PM
|
Re: New Docs
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 30, 2016 01:16PM
|
Re: New Docs
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 31, 2016 02:30PM
|
Re: New content on Publications page of RVX website
|
4
|
Resverlogix Corp.
|
Jun 09, 2016 02:13PM
|
Re: New compound - ApaBearDownAzone
|
5
|
Resverlogix Corp.
|
Jun 01, 2017 03:23PM
|
Re: New CEO
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 24, 2017 09:07PM
|
Re: New CEO
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 24, 2017 09:26PM
|
Re: NEW BLOG POST
|
6
|
Resverlogix Corp.
|
Jun 18, 2015 11:25AM
|
Re: NEW BLOG POST
|
5
|
Resverlogix Corp.
|
Jun 25, 2015 02:14PM
|
Re: New blog post
|
2
|
Resverlogix Corp.
|
May 28, 2015 02:02PM
|
Re: New ATB blog posting:
|
5
|
Resverlogix Corp.
|
Aug 16, 2016 03:35AM
|
Re: New Article posted in the Journal of the American College of Cardiology
|
6
|
Resverlogix Corp.
|
Nov 01, 2016 01:42PM
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
4
|
Resverlogix Corp.
|
Jan 30, 2019 03:09PM
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 04:00PM
|
Re: New article on Apabetalone
|
9
|
Resverlogix Corp.
|
Oct 16, 2017 04:23PM
|
Re: New article from The Life science report
|
1
|
Resverlogix Corp.
|
Sep 06, 2016 11:26AM
|